All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

EQT opts for mezz to back BSN buyout as high yield bonds struggle to compete

With Europe’s high yield market all but closed, mezzanine lenders underscored their product’s reliability and potential competitiveness this week by delivering €391.5m of junior debt for EQT’s leveraged buy-out of BSN Medical, write Olly West and Stefanie Linhardt.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree